Search Results 231-240 of 17617 for CABG

  1. Coagulation Test Changes Associated with Acute Normovolemic Hemodilution in Cardiac Surgery - Mayo Clinic

    About this study. The specific aim of this study is to determine best practice in management of cardiac surgical patients with post- cardiopulmonary bypass ...

  2. CV Research Booklet - MC5751-13

    Heart Failure. Rick A. Nishimura, MD ...............................46. Steve R. Ommen, MD ..................................47. Garvan C. Kane, MD, PhD .

  3. A Study to Evaluate Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having Heart Failure with Preserved Ejection Fraction - Mayo Clinic

    MI (type I) and/or percutaneous cardiac intervention within 3 months prior to screening, CABG in past 3 months prior to screening, or current indication for ...

  4. Video Archive - Spontaneous Coronary Artery Dissection (SCAD) Research Program

    Find additional videos from the Mayo Clinic Spontaneous Coronary Artery Dissection (SCAD) Research Program.

  5. Publications - Trevor J. Simard, M.D., Ph.D. - Mayo Clinic

    ... CABG trial. BMJ Open. 2022 Apr 08; 12(4):e055580. View PubMed; Simard T, Lloyd J, Crestanello J, Thaden JJ, Alkhouli M, Guerrero M, Rihal CS, Eleid MF. Five ...

  6. A Study to Evaluate Dapagliflozin to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure - Mayo Clinic

    MI, unstable angina, coronary revascularization (percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG)), ablation of atrial ...

  7. nMARQ™ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation - Mayo Clinic

    Coronary artery bypass graft (CABG) procedure within the last 180 days (6 months). Awaiting cardiac transplantation or other cardiac surgery within the next ...

  8. Cardiovascular Medicine - Clinical trials

    Rochester, Minn. Spontaneous coronary artery dissection (SCAD) is uncommon but important cause of acute coronary syndrome and sudden cardiac death. There is ...

  9. REDUCE LAP-HF TRIAL II - Mayo Clinic

    MI and/or percutaneous cardiac intervention within past 3 months; CABG in past 3 months, or current indication for coronary revascularization; AVR (surgical ...

  10. A Phase I/II, open-label, multi-center trial of [177Lu]Lu-NeoB in combination with capecitabine in adult patients with GRPR+, ER+, HER2- metastatic breast cancer after progression on previous endocrine therapy in combination with a CDK4/6 inhibito - Mayo Clinic

    Documented myocardial infarction (MI), angina pectoris, cardiomyopathy, symptomatic pericarditis, or coronary artery bypass graft (CABG) within 6 months prior ...